Want to see AU:NSB full AI Analyst Report?
Total Valuation
Neuroscientific Biopharmaceuticals Ltd. has a market cap or net worth of AU$24.16M. The enterprise value is AU$15.52.
Market CapAU$24.16M
Enterprise ValueAU$15.52
Share Statistics
Neuroscientific Biopharmaceuticals Ltd. has 389,718,540 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding389,718,540
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neuroscientific Biopharmaceuticals Ltd.’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -31.58%.
Return on Equity (ROE)-0.32
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-31.58%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee0.00
Profits Per Employee-521.46K
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Neuroscientific Biopharmaceuticals Ltd. is ―. Neuroscientific Biopharmaceuticals Ltd.’s PEG ratio is -0.41.
PE Ratio―
PS Ratio0.00
PB Ratio1.34
Price to Fair Value1.34
Price to FCF0.00
Price to Operating Cash Flow-7.59
PEG Ratio-0.41
Income Statement
In the last 12 months, Neuroscientific Biopharmaceuticals Ltd. had revenue of 0.00 and earned -4.69M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit-1.38M
Operating Income-5.11M
Pretax Income-5.10M
Net Income-4.69M
EBITDA-3.72M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.78M and capital expenditures 0.00, giving a free cash flow of -2.78M billion.
Operating Cash Flow-2.78M
Free Cash Flow-2.78M
Free Cash Flow per Share>-0.01
Dividends & Yields
Neuroscientific Biopharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.57
52-Week Price Change-61.25%
50-Day Moving Average0.06
200-Day Moving Average0.09
Relative Strength Index (RSI)46.72
Average Volume (3m)171.23K
Important Dates
Neuroscientific Biopharmaceuticals Ltd. upcoming earnings date is Mar 3, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateMar 3, 2027
Ex-Dividend Date―
Financial Position
Neuroscientific Biopharmaceuticals Ltd. as a current ratio of 14.27, with Debt / Equity ratio of 0.59%
Current Ratio14.27
Quick Ratio14.27
Debt to Market Cap<0.01
Net Debt to EBITDA0.68
Interest Coverage Ratio-1.39K
Taxes
In the past 12 months, Neuroscientific Biopharmaceuticals Ltd. has paid -402.66K in taxes.
Income Tax-402.66K
Effective Tax Rate0.08
Enterprise Valuation
Neuroscientific Biopharmaceuticals Ltd. EV to EBITDA ratio is -4.66, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA-4.66
EV to Free Cash Flow0.00
EV to Operating Cash Flow-6.66
Balance Sheet
Neuroscientific Biopharmaceuticals Ltd. has AU$4.63M in cash and marketable securities with AU$87.04K in debt, giving a net cash position of AU$4.54M billion.
Cash & Marketable SecuritiesAU$4.63M
Total DebtAU$87.04K
Net CashAU$4.54M
Net Cash Per ShareAU$0.01
Tangible Book Value Per ShareAU$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Neuroscientific Biopharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-10.32%